Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas
Status:
Withdrawn
Trial end date:
2023-05-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if microtransplantation (MST) in combination with
nivolumab is safe and effective in patients with relapsed or refractory B cell lymphomas.